| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.22 | 2e-08 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-07 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.14 | 5e-06 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.17 | 7e-06 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.16 | 7e-06 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.14 | 4e-05 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |